Hancock Whitney’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,811
Closed -$131K 841
2021
Q2
$131K Buy
12,811
+434
+4% +$4.58K ﹤0.01% 796
2021
Q1
$148K Hold
12,377
0.01% 743
2020
Q4
$113K Hold
12,377
﹤0.01% 768
2020
Q3
$75K Hold
12,377
﹤0.01% 771
2020
Q2
$110K Buy
+12,377
New +$107K ﹤0.01% 758
2016
Q1
Sell
-11,097
Closed -$121K 590
2015
Q4
$121K Sell
11,097
-2,300
-17% -$20.8K 0.01% 511
2015
Q3
$91K Buy
+13,397
New +$104K ﹤0.01% 502

Other funds holding NPTN

Hancock Whitney's NPTN Position: Q3 2021 in Review

Hancock Whitney sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 12,811 shares — an estimated $131K sold.

Hancock Whitney first reported a position in NPTN in Q3 2015 and held it in 7 quarters. The position peaked at $148K in Q1 2021. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

  • Hancock Whitney reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 12,811 NEOPHOTONICS CORP shares in Q3 2021, an estimated $131K.
  • Hancock Whitney first reported a position in NEOPHOTONICS CORP in Q3 2015 and held it in 7 quarters.
  • Hancock Whitney's NEOPHOTONICS CORP position peaked at $148K in Q1 2021.
  • 124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.